(28) There were no statistically significant differences in amputation risk between GLP-1s, SGLT-2 inhibitors, DPP4-Is, and all other agents
Abstract Purpose of Review This review provides a comprehensive and scholarly examination of glucagon-like peptide-1 receptor (GLP-1R) agonists, tracing their evolution from glycemic control agents in diabetes mellitus (DM) to multifaceted therapeutics with expanding indications in cardiovascular, renal, and metabolic health
Taquiarritmias Las taquicardias supraventriculares (TSV) deben ser tratadas si son sostenidas y se asocian con hidropesa fetal o cuando haya pruebas de pre excitacin de la aurcula izquierda y un pequeo agujero oval
Molecular Composition and Mechanistic Profile GLP-1S (Glucagon-Like Peptide-1 Analog): A synthetic peptide modeled on the naturally occurring incretin hormone GLP-1(7-36)amide or GLP-1(7-37), produced from proglucagon in intestinal L-cells
Introduction to Glutathione Injection Glutathione is widely recognized as one of the most vital endogenous antioxidants produced within the human body